{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/73fe3ede-5c5c-4850-96a8-30db8dbae8bf/6924ff29e5cc28ec3b2ac476?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How Ireland became the weak spot in Europe’s defences","description":"<p>Traders are piling into bets that Wednesday’s UK Budget will push the pound lower against the dollar, and the pharmaceutical industry saw some promising — and not so promising — clinical trial results. Plus, US tech stocks leapt on Monday and Ireland’s military neutrality has created a weak spot in Europe’s defences.&nbsp;</p><p><br></p><p><strong>Mentioned in this podcast:</strong></p><p><a href=\"https://on.ft.com/4ijlLHW\" rel=\"noopener noreferrer\" target=\"_blank\">Currency traders bet against sterling ahead of Budget</a></p><p><a href=\"https://on.ft.com/4ieit8E\" rel=\"noopener noreferrer\" target=\"_blank\">Novo Nordisk shares slump after drug failure in Alzheimer’s trial</a></p><p><a href=\"https://on.ft.com/4igOtcx\" rel=\"noopener noreferrer\" target=\"_blank\">Bayer soars on promising trial results for stroke prevention drug</a></p><p><a href=\"https://on.ft.com/44tQ4Wq\" rel=\"noopener noreferrer\" target=\"_blank\">US tech stocks surge as Fed rate cut bets fuel rebound</a></p><p><a href=\"https://on.ft.com/3XTS1aZ\" rel=\"noopener noreferrer\" target=\"_blank\">How Ireland became the weak spot in Europe’s defences</a></p><p><br></p><p>Note: The FT does not use generative AI to voice its podcasts&nbsp;</p><p><br></p><p>Today’s FT News Briefing was hosted and edited by <a href=\"https://www.ft.com/marc-filippino\" rel=\"noopener noreferrer\" target=\"_blank\">Marc Filippino</a>, and produced by Fiona Symon, and Sonja Hutson. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.</p><p><br></p><p><a href=\"https://www.ft.com/content/d93c336a-595d-445f-ab59-16219bf6121c\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Read a transcript of this episode on FT.com</strong></a></p>","author_name":"Financial Times"}